title: An evaluation of the TCu 380Ag and the Multiload Cu375.
abstract: The TCu 380Ag (Outokumpu Oy, Pori, Finland) and the Multiload Cu375 (Multilan, Organon, Oss, The Netherlands) were evaluated in 1477 women in a multicenter clinical trial. The intrauterine devices showed similar, low-event rates. Cumulative life-table pregnancy rates were less than 1.0, and continuation rates were approximately 90 per 100 women at 1 year after insertion. The risk of subsequent hospitalization or pelvic infection was low.
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D004867:Equipment Design; D004869:Equipment Safety; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007435:Intrauterine Devices, Copper / Q000009:adverse effects; D010146:Pain / Q000209:etiology; D010388:Pelvis; D011247:Pregnancy; D011897:Random Allocation; D014592:Uterine Hemorrhage / Q000209:etiology